Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

December 28, 2017 by Alan Khadavi

Do Asthma Spacers Help?

asthma spacers

The use of asthma spacers for asthma management has been widely accepted for years.  However, a remaining concern is that incorrect use of a spacer is common and may lead to poor asthma control.  Asthma spacers can be used in conjunction with short acting beta agonists and inhaled corticosteroids.  Coordinating device sprays while inhaling an […]

Filed Under: Asthma, Blog, Pediatric

December 28, 2017 by Alan Khadavi

Severe Hives Treatment (Xolair and Cyclosporine)

new urticaria

Severe hives or chronic spontaneous urticaria is classified as hives with or without swelling that occurs for 6 weeks or more with an unknown cause.  The prevalence of chronic hives (also known as chronic idiopathic urticaria) is approximately 0.5% to 5% of the population.  Chronic hives may be active for 1-5 years at a time, […]

Filed Under: Blog, Urticaria

December 19, 2017 by Alan Khadavi

Do Bleach Baths Improve Eczema?

bleach baths

Eczema or atopic dermatitis is a chronic, relapsing inflammatory skin disorder affecting 15%-20% of children and 1%-10% of adults in the U.S. and worldwide.  Deficiencies in the skin barrier and immune system dysfunction contribute to eczema, resulting in dryness and itching.  Eczema patients are predisposed to to skin infections and patients have a high concentration […]

Filed Under: atopic dermatitis, Blog, Pediatric

December 18, 2017 by Alan Khadavi

Epinephrine Prescriptions after Anaphylaxis

epinephrine

National guidelines recommend that patients with anaphylaxis be prescribed an epinephrine auto-injector (i.e. EpiPen) and referred to an allergy specialist.  In this study we look at what percentage of patients are given epinephrine injectors and referred to see an allergy doctor upon discharge from the emergency room after an anaphylaxis episode. Anaphylaxis is a life […]

Filed Under: Anaphylaxis, Blog, drug allergy, Food allergy

December 5, 2017 by Alan Khadavi

Chocolate Allergy

chocolate allergy

Chocolate allergy contrary to popular belief, is a very rare food allergy.  Complaints can range from headache, heartburn, stomachache and in some cases anaphylaxis.  More likely you can be allergic to another ingredient in chocolate or you may be intolerant to chocolate. To make cacao beans, they are roasted, grounded and melted into chocolate liquor. […]

Filed Under: Blog, Food allergy

November 27, 2017 by Alan Khadavi

Auvi-Q 0.1 mg dose approved for infants and children

auvi-q 0.1 mg

Auvi-Q 0.1 mg dose was recently approved by the FDA for infants and small children weighing 16.5-33 pounds.  Currently there are only 2 dosages on the market for injectable epinephrine, 0.15 mg and 0.3 mg.  The 0.3 mg dose is for anyone over 66 pounds and 0.15 mg for anyone below it.  There was an […]

Filed Under: Anaphylaxis, Blog, Pediatric

November 14, 2017 by Alan Khadavi

Azithromycin for Asthma, as Add-On Therapy

azithromycin

In a study recently published in Lancet, it found that azithromycin add-on therapy reduces exacerbation frequency and improves quality of life in asthmatic patients.  There is currently a strong need to prevent asthma exacerbation in patients with uncontrolled asthma.  Many new biological medications have come on the market recently to treat this segment of the population. […]

Filed Under: Asthma, Blog

November 3, 2017 by Alan Khadavi

EpiPen Failure, can epinephrine injectors improve?

xolair for idiopathic anaphylaxis

The FDA has reported 228 complaints and 7 deaths this year for possible Epipen failure.  The FDA received 4 complaints in 2012 for Epipen failure.  They also reported 35 cases of hospitalizations.  The FDA warned: “There is no certainty that the reported event … was due to the product.” Epipen Failure News Link Food related […]

Filed Under: Anaphylaxis, Blog

October 25, 2017 by Alan Khadavi

Fungal Sensitivity and Asthma

fungal sensitivity

Fungal sensitivity can be seen in patients with severe asthma.  Asthma is characterized by airway inflammation and lung hypersensitivity.  Airway inflammation can be controlled with inhaled steroids, however some patients can continue to experience symptoms even though they are on high dose steroids, long acting beta agonists and leukotriene antagonists. Many allergens, including indoor and […]

Filed Under: Asthma, Blog

October 20, 2017 by Alan Khadavi

Fasenra (Benralizumab) for Severe Asthma

fasenra

Fasenra (benralizumab) is a new 30 mg subcutaneous injection being developed by AstraZeneca.  Fasenra has been shown to help patients with severe asthma cut back on oral steroids.  Fasenra is the trade/brand name of the monoclonal antibody, Benralizumab.  Benralizumab (Fasenra) binds to the alpha chain of the IL-5 receptor present on both eosinophils and basophils, […]

Filed Under: Allergy Medicine, Blog

  • « Previous Page
  • 1
  • …
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 57
  • Next Page »

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page